The Bedrock of Biotech
Genetic Engineering & Biotechnology News (GEN) stands as a cornerstone in the biotechnology sector, offering comprehensive coverage and insights. Located at 140 Huguenot St, New Rochelle, New York 10801, US, Genetic Engineering & Biotechnology News delivers essential information to researchers and executives through its magazine, website, eNewsletters, and multimedia resources.
Genetic Engineering & Biotechnology News provides unrivaled editorial content across the life sciences. Its coverage includes drug discovery, bioprocessing, OMICS, translational medicine, and gene editing, with an expanding focus on cancer research, infectious diseases, and artificial intelligence. Genetic Engineering & Biotechnology News excels in delivering industry news, insights into cutting-edge tools and technologies, industry-standard protocols, and reports from scientific and industry meetings.
With its dedication to quality and comprehensive coverage, Genetic Engineering & Biotechnology News continues to be a vital resource for the biotechnology community. We invite the manager of Genetic Engineering & Biotechnology News to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and reach.
Genetic Engineering & Biotechnology News (GEN) est une pierre angulaire dans le secteur de la biotechnologie, offrant une couverture et des informations complètes. Situé au 140 Huguenot St, New Rochelle, New York 10801, États-Unis, Genetic Engineering & Biotechnology News fournit des informations essentielles aux chercheurs et aux cadres grâce à son magazine, son site Web, ses newsletters électroniques et ses ressources multimédias.
Genetic Engineering & Biotechnology News offre un contenu éditorial inégalé dans le domaine des sciences de la vie. Sa couverture comprend la découverte de médicaments, le bioprocédé, l'OMICS, la médecine translationnelle et l'édition génique, avec un accent croissant sur la recherche sur le cancer, les maladies infectieuses et l'intelligence artificielle. Genetic Engineering & Biotechnology News excelle dans la diffusion d'informations sur l'industrie, d'informations sur les outils et technologies de pointe, de protocoles standard de l'industrie et de rapports de réunions scientifiques et industrielles.
Grâce à son dévouement à la qualité et à sa couverture complète, Genetic Engineering & Biotechnology News reste une ressource essentielle pour la communauté biotechnologique. Nous invitons le responsable de Genetic Engineering & Biotechnology News à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, améliorant ainsi leur visibilité et leur portée.
Compare Genetic Engineering & Biotechnology News with 3 companies in Book-and-Periodical-Publishing
| Comparison Field |
Genetic Engineering & Bio...Main Company |
Foundation for Negle...View Profile |
AMPLY DiscoveryView Profile |
NeoPhore LtdView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2021 | 2017 |
|
Company Size
|
— | 11-50 | 2-10 | 2-10 |
|
City
|
New Rochelle, New York | Bangalore, Karnataka | Belfast, Northern Ireland | Cambridge, Cambridgeshire |
|
Country
|
United States | India | United Kingdom | United Kingdom |
|
Skills & Keywords
Comparing with main company
|
9 Total Skills
Biotechnology News
Drug Discovery
Bioprocessing
OMICS
Translational Medicine
Gene Editing
Life Sciences
Biotechnology
Genome Editing
|
7 Total
7 Unique
Unique Skills:
Diagnostics Research
Infectious Diseases
Malaria
Microbiology
Neglected Diseaes
Preclinical Research
+1
|
13 Total
13 Unique
Unique Skills:
AI
Animal Health
Anti-infectives
Bioinformatics
Biologics
Cancer
+7
|
5 Total
5 Unique
Unique Skills:
Cancer
Genetics
Immuno-oncology
Oncology
Small Molecule Therapeutics
|
Other organizations in the same industry
This company is also known as